Jasperate, Inc. is a startup company in the truest sense. We have a strong management team with extensive industry experience. We are the owners of a pending patent for a J-ject needle⢠that will assist doctors and medical professionals improve their patient care through the use of improved hypodermic needles. Source
No articles found.
Forty Seven is a clinical-stage immuno-oncology company focused on developing nove...
Forty Seven is a clinical-stage immuno-oncology...
Our mission is to improve the lives of patients by developing novel, best-in-class...
Our mission is to improve the lives of patients...
Adaptimmune is a leader in TCR T-cell therapy, focused on developing novel cancer ...
Adaptimmune is a leader in TCR T-cell therapy, ...
Jeeva Medical Corp is here to disrupt digital healthcare and empower people to tak...
Jeeva Medical Corp is here to disrupt digital h...
Compugen is a drug discovery company with a unique, broadly applicable, predictive...
Compugen is a drug discovery company with a uni...
HTG Molecular Diagnostics, Inc. ("HTG") is a provider of instruments, reagents, an...
HTG Molecular Diagnostics, Inc. ("HTG") is a pr...
FUJIFILM is in development, production, sales, and service of: Imaging Solutions (...
FUJIFILM is in development, production, sales, ...
Join the National Investor Network and get the latest information with your interests in mind.